SENSEX 73,808.32
NIFTY 23,248.45
CRUDEOIL 9,089.00
+ 139.00
GOLD 154,777.00
Alkem Laboratories shares drop over 1% after ₹930 crore promoter stake sale, with trading volatility observed throughout the session.
Alkem promoters sold 1.5% stake (₹930 crore) to institutional investors, reducing control to 49.71% and triggering founder Jayanti Sinha's exit. The stake sale signals ownership transition in a large-cap pharma play, with MNCs and domestic funds gaining foothold.
SENSEX 73,808.32
NIFTY 23,248.45
CRUDEOIL 9,089.00
+ 139.00
GOLD 154,777.00

Alkem Labs shares in focus as Goldman, Morgan Stanley, others purchase stake in Rs 930-crore block deal

Alkem Labs sees Rs 930 crore block deal as promoter family entities pare stake; Goldman, Morgan Stanley among key buyers

Stocks in news: Alkem Labs, Vedanta, Canara Bank, NHPC, Adani Ports

Alkem Laboratories promoters sold a 1.5% stake for Rs 930 crore. Promoter holding fell below 50% as mutual funds and global…

Shares of Alkem Laboratories will be in focus after block deals worth around Rs 930 crore saw 17.88 lakh shares traded at Rs…

Alkem Laboratories shares experienced significant block deals totaling Rs 930 crore. Promoter family entities divested shares to…

Markets closed higher on weekly expiry day despite volatility, with Nifty showing signs of recovery but facing resistance around…

Shares of Alkem Laboratories surged over 6 per cent in early trade on Friday after the company reported strong revenue growth for…

DOMS shares drop nearly 2% despite strong revenue growth, reflecting market volatility and investor sentiment ahead of Q4 results.